Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Carreira
Erick Carreira, Zumikon CH
| Patent application number | Description | Published |
|---|---|---|
| 20090186838 | Amphotericin Derivatives - The present invention provides new polyene macrolide derivatives which show very low toxicity while retaining high antifungal activity as compared with amphotericin B (AmB). These polyene macrolide derivatives comprise a polyene macrolide backbone having at least one free amino group, wherein the amino group is doubly alkylated with at least one hydrocarbon group carrying a total of at least two basic groups. | 07-23-2009 |
| 20090275524 | NOVEL HYPOCHOLESTEROLEMIC COMPOUNDS - The present invention relates to novel hypocholesterolemic compounds of formula (I) useful in the treatment and prevention of atherosclerosis and for the reduction of cholesterol levels as well as to pharmaceutical compositions comprising said compounds alone or in combination with other active agents | 11-05-2009 |
| 20110172464 | PROCESS FOR THE SYNTHESIS OF A PROPARGYLIC ALCOHOL - A process for the preparation of the compound of formula | 07-14-2011 |
| 20120029237 | Autocatalytic Process for the Synthesis of Chiral Propargylic Alcohols - An autocatalytic process for the synthesis of chiral propargylic alcohols. | 02-02-2012 |
Erick M. Carreira, Zurich CH
| Patent application number | Description | Published |
|---|---|---|
| 20090054689 | PHOSPHORAMIDITE LIGAND AND PRODUCTION METHOD OF ALLYLIC AMINE USING THE SAME - The present invention provides a production method of an allylic amine represented by the formula (III): | 02-26-2009 |
| 20100016618 | CHIRAL IRIDIUM AQUA COMPLEX AND METHOD FOR PRODUCING OPTICALLY ACTIVE HYDROXY COMPOUND BY USING THE SAME - The invention relates to a chiral iridium aqua complex of formula (1): | 01-21-2010 |
| 20110054171 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE AMINES - Salts of optically active [4-(2-diphenylphosphanylnaphthalen-1-yl)phthalazin-1-yl]-(1-phenylethyl)amines represented by the formulas (1) to (4) with an optically active organic sulfonic acid, and a production method thereof. | 03-03-2011 |
| 20110137049 | CHIRAL IRIDIUM AQUA COMPLEX AND METHOD FOR PRODUCING OPTICALLY ACTIVE HYDROXY COMPOUND USING THE SAME - The invention provides a chiral iridium aqua complex which has good preservation stability, can be easily produced, and enables asymmetric transfer hydrogenation in a higher yield and with higher stereoselectivity. The chiral iridium aqua complex has the formula (1A): | 06-09-2011 |
Joao Pedro Carreira, Pourriere FR
| Patent application number | Description | Published |
|---|---|---|
| 20100283651 | CYCLIC DIGITAL TO ANALOG CONVERTER - Some embodiments include apparatus and methods having an amplifier, a capacitor network coupled to the amplifier, and switching circuitry coupled to the amplifier and the capacitor network. The switching circuit is configured to successively apply a selected reference voltage selected from among a first reference voltage, a second reference voltage, and a third reference voltage to the capacitor network in response to a digital input code to generate an output voltage. Additional embodiments are disclosed. | 11-11-2010 |
Raquel Sousa Carreira, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120042398 | COMPOSITIONS FOR LABELING AND IDENTIFYING AUTOPHAGOSOMES AND METHODS FOR MAKING AND USING THEM - The invention provides methods and compositions for detecting and measuring the amount of autophagosomes in cells or tissues, including biopsy samples, in vitro, in situ and/or in vivo. By detecting and measuring the amount of autophagosomes in cells or tissues, the methods and compositions of the invention also measure the amount of autophagic activity in a cell or a tissue. In one aspect, the invention can be adapted to a plate-reader format for high-throughput screening of drugs that modulate autophagy, i.e., high-throughput detection of autophagic (autophagosome) activity in cells or tissues. In alternative embodiments, the compositions of the invention can localize into autophagosomes (AV), and these compositions can comprise any detectable moiety or group, e.g., a cadaverine, a radioactive, fluorescent-, bioluminescent and/or paramagnetic-conjugated reagent. | 02-16-2012 |